Geez Dingo - you really have turned into a negative young fellow.
I would call this move PRUDENT financial management.
Off-loading an asset that was not adding to the business - and getting case and ongoing savings has to be seen as real positive. Plus, an agreement to get the use of the facility to meet trial requirements.
Then add the lengthening of the funding runway to 2026.
You'd have to work really hard to see any flaws in this arrangement.
Ann: Imugene and Kincell Bio Announce Strategic Partnership, page-43
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.4¢ |
Change
-0.001(1.82%) |
Mkt cap ! $396.8M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.6¢ | 5.4¢ | $443.4K | 8.072M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 27 | 3056419 | 5.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.5¢ | 120000 | 1 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |